Can Ficicioglu
Professor of Pediatrics (Human Genetics) at the Children's Hospital of Philadelphia
Director, The Children's Hospital of Philadelphia, Division of Human Genetics, Newborn Metabolic Screening Program
Consultant Physician, Pennsylvania Hospital-Neonatology
Consultant Physician, Hospital of University of Pennsylvania- Neonatology
Director, The Children's Hospital of Philadelphia, Division of Human Genetics, Lysosomal Storage Diseases Program
Director, Section of Biochemical Genetics, The Children's Hospital of Philadelphia, Division of Human Genetics
Department: Pediatrics
Contact information
Division of Human Genetics
The Children's Hospital of Philadelphia
3501 Civic Center Blvd #9054.
Philadelphia, PA 19104
The Children's Hospital of Philadelphia
3501 Civic Center Blvd #9054.
Philadelphia, PA 19104
Office: 215 590 3376
Fax: 215 590 4297
Fax: 215 590 4297
Email:
Ficicioglu@email.chop.edu
Ficicioglu@email.chop.edu
Education:
MD
University of Istanbul, Cerrahpasa Medical School (with High Honors), 1985.
PhD (Histology & Embryology)
University of Marmara, 1996.
MD
University of Istanbul, Cerrahpasa Medical School (with High Honors), 1985.
PhD (Histology & Embryology)
University of Marmara, 1996.
Post-Graduate Training
Residency in Pediatrics, Department of Pediatrics, University of Istanbul, Cerrahpasa Medical School, Children's Hospital, 1986-1991.
Clinical Fellow, Division of Genetics/Metabolism, Harvard Medical School, Children’s Hospital Boston, 1998-2000.
Senior Resident, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein Medical College., 2000-2001.
Senior Resident, Department of Pediatrics, New York Medical College, St. Vincent’s Medical Center, 2001-2002.
Permanent linkResidency in Pediatrics, Department of Pediatrics, University of Istanbul, Cerrahpasa Medical School, Children's Hospital, 1986-1991.
Clinical Fellow, Division of Genetics/Metabolism, Harvard Medical School, Children’s Hospital Boston, 1998-2000.
Senior Resident, Department of Pediatrics, Children's Hospital at Montefiore, Albert Einstein Medical College., 2000-2001.
Senior Resident, Department of Pediatrics, New York Medical College, St. Vincent’s Medical Center, 2001-2002.
Description of Itmat Expertise
Dr. Ficicioglu is developing algorithms for the effective short and long-term care of patients detected by newborn screening, and new drugs to treat lysosomal storage disorders.Selected Publications
Posset R et al : Severity-adjusted evaluation of liver transplantation on health outcomes in Urea Cycle Disorders Genetics in Medicine 2023.Katler Q, Stepien KM, Paull N, Patel S, Adams M, Balci MC, Berry GT, Bosch AM, De La O A, Demirbas D, Edman J, Ficicioglu C, Goff M, Hacker S, Knerr I, Lancaster K, Li H, Mendelsohn BA, Nichols B, de Rezende Pinto WBV, Rocha JC, Rubio-Gozalbo ME, Saad-Naguib M, Scholl-Buergi S, Searcy S, de Souza PVS, Wittenauer A, Fridovich-Keil JL: A Multinational Study of Acute and Long-term Outcomes of Type 1 Galactosemia Patients Who Carry the S135L (c.404C>T) Variant of GALT. J Inherit Metab Dis Sept 2022.
Brower A, Chan K, Williams M, Berry S, Currier R, Rinaldo P, Caggana M, Gaviglio A, Wilcox W, Steiner R, Holm IA, Taylor J, Orsini JJ, Brunelli L, Adelberg J, Bodamer O, Viall S, Scharfe C, Wasserstein M, Chen JY, Escolar M, Goldenberg A, Swoboda K, Ficicioglu C, Matern D, Lee R, Watson M.: Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One) Front Genet. 2 Jul 2022.
Ficicioglu C, Liu N, Sun Q, Burdett A, Hata A, Porter M, Sutton VR.: Perceptions and use of phenylbutyrate metabolite testing in urea cycle disorders: Results of a clinician survey and analysis of a centralized testing database. Mol Genet Metab. Page: 35-41, January 2022.
Szigety KM, Crowley TB, Gaiser KB, Chen EY, Priestley JRC, Williams LS, Rangu SA, Wright CM, Adusumalli P, Ahrens-Nicklas RC, Calderon B, Cuddapah SR, Edmondson A, Ficicioglu C, Ganetzky R, Kalish JM, Krantz ID, McDonald-McGinn DM, Medne L, Muraresku C, Pyle LC, Zackai EH, Campbell IM, Sheppard SE.: Clinical Effectiveness of Telemedicine-Based Pediatric Genetics Care. Pediatrics 2022.
Priestley J, Adang L, Williams SD, Lichter-Konecki U, Menello C, Engelhardt N, DiPerna J, Brenda DiBoscio B, Rebecca C. Ahrens-Nicklas RC, Edmondson AC , Reynoso J and Ficicioglu C: Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania. International Journal of Neonatal Screening 2022.
Gold J, Gold NB, Strong A, Tully E, Xiao R ,Schwartz LA, Ficicioglu C: The Current State of Adult Metabolic Medicine in the United States: Results of a Nationwide Survey. Genetics in Medicine 2022 Notes: accepted for publication
Čechová A, Honzík T, Edmondson AC, Ficicioglu C, Serrano M, Barone R, De Lonlay P, Schiff M, Witters P, Lam C, Patterson M, Janssen MCH, Correia J, Quelhas D, Sykut-Cegielska J, Plotkin H, Morava E, Sarafoglou K. : Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency? Mol Genet Metab 133(4): 397-399, August 2021.
Gold JI, Campbell IM, Ficicioglu C. : Provider Perspectives on the Impact of the COVID-19 Pandemic on Newborn Screening. Int J Neonatal Screen. 7(3): 38, July 2021.
Ficicioglu C, Demirbas D, Derks B, Pai GS, Timson DJ, Rubio-Gozalbo ME, Berry GT.: [13C]-galactose breath test in a patient with galactokinase deficiency and spastic diparesis. JIMD Rep. 59(1): 104-109, Feb 2021.